BIOMAT Database Logo BIOMAT Database Logo

Gram-negative bacillary infections in cancer patients. 1977

G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating

The majority of infectious complications in cancer patients are caused by Gram-negative bacilli. The most common organisms are Escherichia coli, Klebsiella spp. and Pseudomonas aeruginosa. Sites of infection are related to the patients' underlying malignancies, but pneumonia and septicaemia occur most often. Important newer antibiotics for the therapy of these infections are aminoglycosides and semisynthetic penicillins. It is advisable to utilize combinations of antibiotics for serious infections in cancer patients, and therapy should be instituted promptly at the onset of infection.

UI MeSH Term Description Entries
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Generalised gram-negative bacillary infections.
January 1972, Journal of the Royal College of Physicians of London,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Immunoprophylaxis of gram-negative bacillary infections.
January 1976, Annual review of medicine,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Oral ciprofloxacin in refractory gram-negative bacillary infections.
January 1987, International journal of clinical pharmacology research,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Netilmicin therapy of serious Gram-negative bacillary infections.
November 1978, The Journal of antimicrobial chemotherapy,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Amikacin therapy for serious gram-negative bacillary infections.
December 1975, Annals of internal medicine,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Gram-negative bacillary infections. Pathogenic and pathophysiologic correlates.
June 1985, The American journal of medicine,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Aztreonam therapy for serious gram-negative bacillary infections.
January 1985, Reviews of infectious diseases,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Netilmicin in the treatment of gram-negative bacillary infections.
March 1983, The Journal of the Medical Society of New Jersey,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
Synergistic combinations of antibiotics in gram-negative bacillary infections.
January 1982, Reviews of infectious diseases,
G P Bodey, and V Rodriguez, and M Valdivieso, and M Keating
[Gram negative bacillary infections in recent years (author's transl)].
January 1979, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!